Literature DB >> 8869706

The surgical treatment of Chiari I malformation.

J Klekamp1, U Batzdorf, M Samii, H W Bothe.   

Abstract

A retrospective study was undertaken on 133 patients with a Chiari I malformation treated within the last 16 years at the Departments of Neurosurgery at the Nordstadt Hospital Hannover, Germany, and the University of California, Los Angeles, U.S.A. Ninety-seven patients presented with symptoms related to accompanying syringomyelia and 4 with associated syringobulbia. They underwent 149 surgical procedures and were followed for a mean of 39 +/- 52 months. A decompression at the foramen magnum was performed in 124 patients, while 22 of those with syringomyelia were treated by shunting (7 syringosubarachnoid shunts, 15 syringoperitoneal or -pleural shunts), and 3 by ventriculoperitoneal shunts for hydrocephalus. Except for ventriculoperitoneal shunting, at least a short-term decrease in size of an associated syrinx was observed for all procedures in the majority of cases. However, no long-term benefit was observed for syrinx shunting operations. The best clinical long-term results were obtained with decompression of the foramen magnum in patients with (86% free of a clinical recurrence) and without syringomyelia (77% free of a clinical recurrence). We advise against syrinx shunting, a large craniectomy, and obex plugging which are associated with higher recurrence rates. Instead, surgery should consist of a small craniectomy, opening of the dura, archnoid dissection to establish normal cerebrospinal fluid (CSF) outflow from the 4th ventricle, and a fascia lata dural graft.

Entities:  

Mesh:

Year:  1996        PMID: 8869706     DOI: 10.1007/bf01411256

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  57 in total

1.  Natural history and postsurgical outcome of syringomyelia.

Authors:  A Boiardi; L Munari; A Silvani; E Porta; A Scuratti; S Lodrini
Journal:  Ital J Neurol Sci       Date:  1991-12

2.  Foramen magnum decompression versus terminal ventriculostomy for the treatment of syringomyelia.

Authors:  F Filizzolo; P Versari; G D'Aliberti; O Arena; G Scotti; C Mariani
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

3.  [Syringomyelia. Clinical follow-up studies in 323 patients].

Authors:  G Hertel; S Kramer; E Placzek
Journal:  Nervenarzt       Date:  1973-01       Impact factor: 1.214

4.  [Clinical picture of syringomyelia].

Authors:  G Schliep; U Ritter
Journal:  Fortschr Neurol Psychiatr Grenzgeb       Date:  1971-02

5.  Chiari malformation presenting in adults: a surgical experience in 127 cases.

Authors:  W J Levy; L Mason; J F Hahn
Journal:  Neurosurgery       Date:  1983-04       Impact factor: 4.654

6.  Chiari I malformations: clinical and radiologic reappraisal.

Authors:  A D Elster; M Y Chen
Journal:  Radiology       Date:  1992-05       Impact factor: 11.105

7.  Central dysesthesia syndrome in spinal cord injury patients.

Authors:  Aleksandar Berić; Milan R Dimitrijević; Ulf Lindblom
Journal:  Pain       Date:  1988-08       Impact factor: 6.961

8.  Congenital malformations of the craniovertebral junction: classification and surgical treatment.

Authors:  A Erbengi; H K Oge
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Intramedullary penetrance of metrizamide in the dog spinal cord.

Authors:  P J Dubois; B P Drayer; M Sage; D Osborne; E R Heinz
Journal:  AJNR Am J Neuroradiol       Date:  1981 Jul-Aug       Impact factor: 3.825

View more
  33 in total

1.  Histological and biomechanical study of dura mater applied to the technique of dura splitting decompression in Chiari type I malformation.

Authors:  Dorian Chauvet; Alexandre Carpentier; Jean-Marc Allain; Marc Polivka; Jérôme Crépin; Bernard George
Journal:  Neurosurg Rev       Date:  2010-05-04       Impact factor: 3.042

Review 2.  Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis.

Authors:  Izumi Koyanagi; Kiyohiro Houkin
Journal:  Neurosurg Rev       Date:  2010-06-08       Impact factor: 3.042

3.  The fate of syringomyelia after surgical treatment of syringomyelia-Chiari I complex.

Authors:  Paolo Perrini; Nicola Di Lorenzo
Journal:  Neurol Sci       Date:  2010-11-30       Impact factor: 3.307

4.  Cardiac-Related Spinal Cord Tissue Motion at the Foramen Magnum is Increased in Patients with Type I Chiari Malformation and Decreases Postdecompression Surgery.

Authors:  Braden J Lawrence; Mark Luciano; John Tew; Richard G Ellenbogen; John N Oshinski; Francis Loth; Amanda P Culley; Bryn A Martin
Journal:  World Neurosurg       Date:  2018-05-04       Impact factor: 2.104

5.  Technical nuances of autologous pericranium harvesting for dural closure in Chiari malformation surgery.

Authors:  Paolo Perrini
Journal:  J Neurol Surg B Skull Base       Date:  2014-09-29

6.  Chiari 1 malformation management: the Red Cross War Memorial Hospital approach.

Authors:  J M N Enslin; A G Fieggen; A Figaji
Journal:  Childs Nerv Syst       Date:  2019-07-03       Impact factor: 1.475

7.  Clinical and radiological outcome of craniocervical osteo-dural decompression for Chiari I-associated syringomyelia.

Authors:  Giannantonio Spena; Claudio Bernucci; Diego Garbossa; Walter Valfrè; Pietro Versari
Journal:  Neurosurg Rev       Date:  2010-05-01       Impact factor: 3.042

8.  Decompressive surgery for Chiari I malformation in children without dural repair: a still effective and safe procedure?

Authors:  Arthur R Kurzbuch; Jayaratnam Jayamohan; Shailendra Magdum
Journal:  Childs Nerv Syst       Date:  2019-06-10       Impact factor: 1.475

9.  Pathophysiology of persistent syringomyelia after decompressive craniocervical surgery. Clinical article.

Authors:  John D Heiss; Giancarlo Suffredini; René Smith; Hetty L DeVroom; Nicholas J Patronas; John A Butman; Francine Thomas; Edward H Oldfield
Journal:  J Neurosurg Spine       Date:  2010-12

10.  Treatment of basilar invagination.

Authors:  Jörg Klekamp
Journal:  Eur Spine J       Date:  2014-06-18       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.